Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (341-350 of 382) with videos related to

Pageof 39
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|February 16, 2008
A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statinsUnni M Breland, Bente Halvorsen, Johanna Hol, et al.
JACC. Heart Failure|April 1, 2017
Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart FailureStåle H Nymo, Pål Aukrust, John Kjekshus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2019
Increased Complement Factor B and Bb Levels Are Associated with Mortality in Patients with Severe Aortic StenosisNegar Shahini, Thor Ueland, Andreas Auensen, et al.
Frontiers in Immunology|September 28, 2018
IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial InfarctionHilde L Orrem, Per H Nilsson, Søren E Pischke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 21, 2006
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilizationWiggo J Sandberg, Arne Yndestad, Erik Øie, et al.
Circulation. Heart Failure|September 23, 2020
YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic StenosisFizza Arain, Aurelija Abraityte, Mariia Bogdanova, et al.
Open Heart|November 2, 2019
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)Anne Kristine Anstensrud, Sindre Woxholt, Kapil Sharma, et al.
Atherosclerosis|July 31, 2012
Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilizationLinda M Smedbakken, Bente Halvorsen, Isabelle Daissormont, et al.
Open Heart|October 30, 2024
Cardiac remodelling in patients with atrial fibrillation and obstructive sleep apnoeaTove Elizabeth Frances Hunt, Gunn Marit Traaen, Lars Aakerøy, et al.
Plos One|May 3, 2011
Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overloadAnne Waehre, Bente Halvorsen, Arne Yndestad, et al.
Pageof 39

Showing results (341-350 of 382) with videos related to

Sort By:
Pageof 39
Arteriosclerosis, Thrombosis, and Vascular Biology|February 16, 2008
A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statinsUnni M Breland, Bente Halvorsen, Johanna Hol, et al.
JACC. Heart Failure|April 1, 2017
Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart FailureStåle H Nymo, Pål Aukrust, John Kjekshus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2019
Increased Complement Factor B and Bb Levels Are Associated with Mortality in Patients with Severe Aortic StenosisNegar Shahini, Thor Ueland, Andreas Auensen, et al.
Frontiers in Immunology|September 28, 2018
IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial InfarctionHilde L Orrem, Per H Nilsson, Søren E Pischke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 21, 2006
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilizationWiggo J Sandberg, Arne Yndestad, Erik Øie, et al.
Circulation. Heart Failure|September 23, 2020
YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic StenosisFizza Arain, Aurelija Abraityte, Mariia Bogdanova, et al.
Open Heart|November 2, 2019
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)Anne Kristine Anstensrud, Sindre Woxholt, Kapil Sharma, et al.
Atherosclerosis|July 31, 2012
Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilizationLinda M Smedbakken, Bente Halvorsen, Isabelle Daissormont, et al.
Open Heart|October 30, 2024
Cardiac remodelling in patients with atrial fibrillation and obstructive sleep apnoeaTove Elizabeth Frances Hunt, Gunn Marit Traaen, Lars Aakerøy, et al.
Plos One|May 3, 2011
Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overloadAnne Waehre, Bente Halvorsen, Arne Yndestad, et al.
Pageof 39